IP Verse

Abbott Diabetes Care Inc. et al. vs DexCom, Inc.

The detailed information for PTAB case with proceeding number IPR2024-00841 filed by Abbott Diabetes Care Inc. et al. against DexCom, Inc. on Apr 26, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2024-00841
Filing Date
Apr 26, 2024
Petitioner
Abbott Diabetes Care Inc. et al.
Respondent
DexCom, Inc.
Status
Terminated-Settled
Respondent Application Number
16690977
Respondent Tech Center
3700
Respondent Patent Number
10709364
Institution Decision Date
Nov 20, 2024
Termination Date
Jan 23, 2025

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice: refund denied

Feb 13, 2025PAPERBOARD

Petitioner Request for Refund

Feb 11, 2025PAPERPETITIONER

TERMINATION Termination Due to Settlement After Institution of Trial and Granting Joint Request to Treat Settlement Agreement as Business Confidential Information 35 U.S.C.317; 37 C.F.R.42.74

Jan 23, 2025PAPERBOARD

Joint Motion to Terminate the Proceedings

Jan 14, 2025PAPERPETITIONER

Joint Request to Treat Settlement Agreement as Business Confidential

Jan 14, 2025PAPERPETITIONER

Ex. 1016 CONFIDENTIAL Settlement Agreement

Jan 14, 2025EXHIBITPETITIONER

Patent Owner's Objections to Evidence

Dec 5, 2024PAPERPATENT OWNER

Order: Scheduling Order

Nov 21, 2024PAPERBOARD

Institution Decision: Grant

Nov 20, 2024PAPERBOARD

Patent Owner's Preliminary Response

Aug 22, 2024PAPERPATENT OWNER

Forlenza 2019

Aug 22, 2024EXHIBITPATENT OWNER

Vaddiraju 2010

Aug 22, 2024EXHIBITPATENT OWNER

Stephens (2018)

Aug 22, 2024EXHIBITPATENT OWNER

Choleau p641-6

Aug 22, 2024EXHIBITPATENT OWNER

Ward

Aug 22, 2024EXHIBITPATENT OWNER

Koschinsky

Aug 22, 2024EXHIBITPATENT OWNER

Frost

Aug 22, 2024EXHIBITPATENT OWNER

Lodwig

Aug 22, 2024EXHIBITPATENT OWNER

Notice filing date accorded to petition

May 22, 2024PAPERBOARD

Notice : Power of Attorney

May 17, 2024PAPERPATENT OWNER

Notice : Mandatory Notice

May 17, 2024PAPERPATENT OWNER

Ex. 1001 - U.S. Patent 10,709,364 ('364 Patent)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1002 - Declaration of Anthony Edward Cass (364 Patent)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1003 - Prosecution File History of US10,709,364

Apr 26, 2024EXHIBITPETITIONER

Ex. 1004 - U.S. Patent 6,275,717 (Gross)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1005 - U.S. Patent Application 2005-0239154A1 (Feldman)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1006 - Feldman Diabetes Tech Ther 2003

Apr 26, 2024EXHIBITPETITIONER

Ex. 1007 - Nishida et al., Development of a ferrocene-mediated (1995)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1008 - Velho et al., Strategies for calibrating (1989)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1009 - Ward et al., A new amperometric glucose (2002)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1010 - U.S. Patent 6,424,847

Apr 26, 2024EXHIBITPETITIONER

Ex. 1011 - U.S. Patent 6,175,572 (Say)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1012 - Heller et al. Implanted Electrochemical Glucose (1999)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1013 - Fraser, Biosensors in the Body Chs 1 and 2

Apr 26, 2024EXHIBITPETITIONER

Ex. 1014 - Scheduling Order (No. 123cv00239, D. Del. Sept. 19, 2023)

Apr 26, 2024EXHIBITPETITIONER

Ex. 1015 - Hall-Ellis Declaration

Apr 26, 2024EXHIBITPETITIONER

Petition : as filed

Apr 26, 2024PAPERPETITIONER

Petitioner Power of Attorney

Apr 26, 2024PAPERPETITIONER